All articles
Understanding vs. Optimization: Two Goals, One Shared Requirement
In academic research, bacterial mutants are primarily designed as experimental tools. Researchers delete, replace, or modify genes to:
- assign gene functions
- validate biological mechanisms
- test scientific hypotheses
In applied microbiology, however, the logic is different. The mutant becomes a strain of interest, for example to:
- optimize a metabolic pathway for bioproduction
- improve process robustness
- enhance the safety or efficacy of a therapeutic bacterium
Regardless of the context, the quality of the mutant directly determines the reliability of the results and the future viability of the project.
Not All Mutants Are Created Equal
Two mutants carrying what appears to be the same genetic modification may behave very differently. The difference often lies not only in the genetic target, but in the strategy used to construct the mutant.
Elements such as resistance cassettes, residual sequences, or unintended genomic alterations can:
- bias phenotype interpretation
- compromise genetic stability
- limit industrial or regulatory usability
A well-designed mutant is therefore not just modified — it is genetically controlled and biologically coherent.
Clean Mutants: A Strategic Choice at Smaltis
At Smaltis, we favor approaches based on homologous recombination to generate what we call clean bacterial mutants, meaning strains that are:
- free of antibiotic resistance markers
- free of genetic scars
- isogenic and genetically stable
This strategy is particularly relevant when the engineered strain must remain scientifically interpretable while also suitable for downstream development.
Our tools—particularly well adapted to Gram-negative bacteria—enable a wide range of genome engineering strategies, including:
- targeted gene knockouts
- precise knock-ins
- point mutations
- rational overexpression strategies
